Assessing patient engagement levels in clinical cancer research: Development of a novel evaluation tool and comparison between eastern and western countries.
Laureline Gatellier(University of Tsukuba), Tomohiro Matsuda, Ingrid Klingmann(European Forum for Good Clinical Practice), Kazuyuki Suzuki(Rakuno Gakuen University), Yoshiyuki Majima(Pancreatic Cancer Action Network), Hadrien Charvat(Juntendo University), Béatrice Serckx, Kenichi Nakamura(Japan Clinical Cancer Research Organization), Bertrand Tombal(Cliniques Universitaires Saint-Luc), Jin Higashijima(Chiba University), Keiko Katsui(St. Marianna University School of Medicine)
Cited by 0
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
|The Lancet|2012|864
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
|The Lancet Oncology|2021|684